近期，我們關注到涉嫌仿冒瑞德醫療口罩產品被美國疾病控制與預防中心（Centers for Disease Control and Prevention，下稱“CDC”）下屬機構檢測為不合格的有關情況，并就此積極采取措施予以應對。為了澄清有關事實、維護瑞德醫療的聲譽及各位消費者、銷售商及合作伙伴的利益，我們特發布此份聲明函，敬請關注。
Dear consumers, distributors and business partners:
Recently, we have learned that a suspected counterfeit RYZUR medical respirator product was assessed as unqualified by a subdivision of the Centers for Disease Control and Prevention (“CDC”), and been actively taking measures to deal with this issue. To clarify relevant facts and to protect RYZUR’s reputation as well as interests of our consumers, distributors and partners, we hereby issue this declaration letter for your information.
請點擊連接下載查看詳情:
聲明函中文版下載:
http://www.bjyqgw.com/uploadfile/2020/0510/20200510102427817.pdf
聲明函英文版（English Version Download）下載:
http://www.bjyqgw.com/uploadfile/2020/0510/20200510110052992.pdf
瑞德醫療與美國CDC/NIOSH之間關于產品CDC不能確定來源的郵件溝通中英文對照文件下載:
The emails communication between RYZUR Medical and CDC / NIOSH about the issue of the testing result which is showing the products samples tested is uncertain:
http://www.bjyqgw.com/uploadfile/2020/0510/20200510112701290.pdf